Transplantation-related toxicity and acute intestinal graft-versus-host disease after conditioning regimens intensified with Rhenium 188-labeled anti-CD66 monoclonal antibodies. - Suppr | 超能文献

Transplantation-related toxicity and acute intestinal graft-versus-host disease after conditioning regimens intensified with Rhenium 188-labeled anti-CD66 monoclonal antibodies.

作者信息

Klein Stefan A, Hermann Stella, Dietrich Johann Wolfgang, Hoelzer Dieter, Martin Hans

出版信息

Blood. 2002 Mar 15;99(6):2270-1. doi: 10.1182/blood.v99.6.2270.

DOI:10.1182/blood.v99.6.2270

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Transplantation-related toxicity and acute intestinal graft-versus-host disease after conditioning regimens intensified with Rhenium 188-labeled anti-CD66 monoclonal antibodies.

Blood. 2002 Mar 15;99(6):2270-1. doi: 10.1182/blood.v99.6.2270.

2

188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia.188铼标记的抗CD66单克隆抗体在高危急性髓系白血病患者干细胞移植中的应用

Leuk Lymphoma. 2002 Nov;43(11):2125-31. doi: 10.1080/1042819021000033015.

3

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study.铼188标记的抗CD66（a、b、c、e）单克隆抗体用于强化高危急性髓系白血病或骨髓增生异常综合征患者干细胞移植前的预处理方案：一项I-II期研究结果

Blood. 2001 Aug 1;98(3):565-72. doi: 10.1182/blood.v98.3.565.

4

Reduced-Intensity Conditioning Combined with (188)Rhenium Radioimmunotherapy before Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: The Role of In Vivo T Cell Depletion.老年急性髓系白血病患者异基因造血干细胞移植前采用低强度预处理联合（188）铼放射免疫疗法：体内T细胞清除的作用

Biol Blood Marrow Transplant. 2015 Oct;21(10):1754-60. doi: 10.1016/j.bbmt.2015.05.012. Epub 2015 May 19.

5

188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.188铼或90钇标记的抗CD66抗体作为55岁以上急性白血病或骨髓增生异常综合征患者剂量降低预处理方案的一部分：一项I-II期研究的结果

Br J Haematol. 2005 Aug;130(4):604-13. doi: 10.1111/j.1365-2141.2005.05663.x.

6

188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation.188Re 抗 CD66 放射性免疫治疗联合减低强度预处理和体内 T 细胞耗竭在老年患者异基因造血细胞移植中的应用。

Br J Haematol. 2010 Mar;148(6):910-7. doi: 10.1111/j.1365-2141.2009.08025.x. Epub 2009 Dec 7.

7

Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.采用¹⁸⁸Re标记的抗CD66抗体进行清髓性放射免疫疗法，用于高危白血病患者干细胞移植前的预处理：生物分布、生物动力学及近期毒性反应

Cancer Biother Radiopharm. 2002 Apr;17(2):151-63. doi: 10.1089/108497802753773775.

8

Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia.用[188Re]标记的抗CD66抗体进行放射免疫治疗，用于高危急性髓系白血病异基因干细胞移植的预处理。

Int J Hematol. 2008 May;87(4):414-421. doi: 10.1007/s12185-008-0043-1.

9

Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study.白血病患者异基因干细胞移植前用放射性标记的抗CD66单克隆抗体进行靶向骨髓照射：一项I-II期研究的结果

Haematologica. 2006 Feb;91(2):285-6.

10

Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease.异基因造血干细胞移植期间的肠道去污与急性移植物抗宿主病的风险

Bone Marrow Transplant. 2018 Aug;53(8):1061-1064. doi: 10.1038/s41409-018-0131-7. Epub 2018 Feb 28.

引用本文的文献

1

Review of Recent Medicinal Applications of Rhenium(I) Tricarbonyl Complexes.铼（I）三羰基配合物近期医学应用综述。

Int J Mol Sci. 2025 Jul 21;26(14):7005. doi: 10.3390/ijms26147005.

2

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives.铼-188标记的放射性药物：目前在肿瘤学中的临床应用及前景展望。

Front Med (Lausanne). 2019 Jun 14;6:132. doi: 10.3389/fmed.2019.00132. eCollection 2019.

3

Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia.用[188Re]标记的抗CD66抗体进行放射免疫治疗，用于高危急性髓系白血病异基因干细胞移植的预处理。

Int J Hematol. 2008 May;87(4):414-421. doi: 10.1007/s12185-008-0043-1.

4

Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.在同基因小鼠白血病模型中使用预靶向抗CD45放射免疫疗法根除播散性白血病

Blood. 2008 Feb 15;111(4):2261-8. doi: 10.1182/blood-2007-06-097451. Epub 2007 Nov 27.